Comments
Commented by Armin Schulz on June 12th, 2024 | 06:45 CEST
Volkswagen changes strategy! Can Power Nickel and Rheinmetall benefit?
In an increasingly volatile global economy, companies face unprecedented challenges and opportunities. Although Volkswagen, Power Nickel, and Rheinmetall may appear to represent different industries at first glance, the companies are often interconnected. Now that Volkswagen, as an automotive giant and key player in the mobility sector, is suddenly adjusting its strategy, it is worth taking a closer look at the impact on other companies. We explain Volkswagen's adjustments and where there are overlaps with Power Nickel and Rheinmetall.
Read
Commented by André Will-Laudien on June 11th, 2024 | 06:45 CEST
After the European elections: Is it all happening now? Nel ASA, Kraken Energy, Siemens Energy, ThyssenKrupp and Nucera in focus
Europe has voted, and the Green parties have suffered historic losses! Now, the energy debate is coming to the fore again. While Germany is focusing entirely on green energy in the future, other countries have long since turned the challenges of the time into action. Nuclear energy remains a "zero-zero solution", making France, the Czech Republic and Poland the biggest climate protection exporters in the EU. This is because many new state-of-the-art reactors are being built here. The electricity market is huge, as Germany alone will have to shut down its gas and coal-fired power plants over the next few years due to the CO2 reduction commitments from the Paris Agreement. This threatens to create a supply gap that can only be filled with alternative energies, nuclear power, or hydrogen. What should investors focus on now?
Read
Commented by Armin Schulz on June 10th, 2024 | 07:15 CEST
Evotec, Vidac Pharma, Bayer - Biotech and Pharma: Opportunities for investors
In the constantly evolving pharmaceutical and biotechnology industry landscape, innovative strength and strategic orientation play a decisive role in success. Both established groups and young, up-and-coming companies are competing for market share and scientific breakthroughs. In this context, it is worth taking a closer look at Vidac Pharma, Bayer and Evotec. These companies are pursuing different approaches and strategies to achieve their respective goals. How do they manage to hold their own in a highly dynamic market environment, and what prospects are emerging for the future?
Read
Commented by Stefan Feulner on June 10th, 2024 | 07:00 CEST
Infineon, MGI - Media and Games Invest, Palantir - These 3 shares are about to break out
Last week was a tough one. Firstly, the European Central Bank heralded the turnaround in interest rates and, as expected, lowered the key interest rate by 25 basis points to 4.25%. Secondly, the hype surrounding meme stocks, and GameStop in particular, was revived by the comeback of influencer Keith Gill, aka Roaring Kitty. Following a live stream on YouTube, the share price soared again and will likely remain a hot topic over the next few trading days.
Read
Commented by André Will-Laudien on June 10th, 2024 | 06:45 CEST
Nasdaq short bets remain dangerous! TUI, Saturn Oil + Gas, Plug Power, and Evotec in the crosshairs
Last week, Nvidia shares gave the bears a scare. Despite massive price gains in recent months, the shares of the specialist for high-performance chips gained another 20%, adding USD 600 billion to its valuation. Now, behind Microsoft, Nvidia is the second most valuable company in the world, surpassing even Apple. Of course, this did not happen without reason because, as of today, the share is trading at 1:10, which means a tenfold increase in the number of shares in the portfolio for shareholders. This does not change the market value per se, as the share price is also reduced by 90% at the opening. The aim is to make the share more accessible and allow retail investors to get involved. Stock splits of this kind are common on the NASDAQ and have often brought investors additional price gains in the following months. Where are the opportunities for investors?
Read
Commented by Juliane Zielonka on June 6th, 2024 | 07:30 CEST
First Hydrogen, RWE, Rheinmetall - Sustainable investments with hydrogen and armaments
According to estimates, the global hydrogen production market will reach USD 230.81 billion by 2030. Both governments and industry are, therefore, in favour of the rapid development of this technology. The Canadian company First Hydrogen has already successfully tested a hydrogen fuel cell-powered van specially developed for the logistics sector. International logistics companies and vehicle manufacturers are now signaling their interest in working together. The energy company RWE is also focusing on hydrogen. The construction of hydrogen power plants in Germany is to be driven forward with two European partners. Rheinmetall, on the other hand, is expanding into the Baltic States. A new ammunition plant is being built in Lithuania. This will result in many lucrative advantages for the German group. Which investment is most likely to yield returns?
Read
Commented by Fabian Lorenz on June 6th, 2024 | 07:15 CEST
Invest in these stocks now! BYD, Varta, Royal Helium!
Those who invest in latecomer stocks now could be rewarded. After all, the high-flyers of 2024 from the fields of artificial intelligence and armaments are anything but cheaply valued. Here are three stocks that could be worth buying now, at least at first glance. BYD has bucked the industry trend by publishing positive sales figures, is making progress in autonomous driving, and analysts are optimistic. Those looking to benefit indirectly from the boom in armaments or quantum computers should consider Royal Helium. A capital increase has injected fresh money into the Company's coffers, and the helium producer can take off again. And what about problem child Varta? The struggling battery manufacturer has found a new CEO, but the old problems remain.
Read
Commented by André Will-Laudien on June 6th, 2024 | 07:00 CEST
Rally start for biotech! Evotec, Bayer, Defence Therapeutics, CureVac and BioNTech in pole position
Sell in May and go Away! Far from it, as the stock markets continue to rise steadily in June. After a disappointing start to the year, the biotech sector is now also showing signs of recovery. Bayer and Evotec seem to have found their footing with improved outlooks. BioNTech, CureVac and Defence Therapeutics are providing promising data on various cancer vaccines. Whoever opens the door here can save millions of lives. And investors stand to make a fortune if one of the vaccines hits the mark. We analyze the opportunities and risks.
Read
Commented by Armin Schulz on June 5th, 2024 | 07:00 CEST
Bayer, Saturn Oil + Gas, TUI - Big price gains beckon here
The shares of Bayer, Saturn Oil & Gas and TUI have the potential to rise in the near future. At Bayer, the negative effects of the challenging year 2023 appear to have been priced in. Saturn Oil & Gas impresses with a strong cash flow and is traded as a future dividend share. Analysts see potential of over 100% here. TUI's balance sheet problems have largely been resolved, and the forecasts for 2024 and the summer season promise record bookings, which could give the share an additional boost - reason enough for us to take a closer look at the three companies.
Read
Commented by Fabian Lorenz on June 5th, 2024 | 06:45 CEST
Share price rise! Nel ASA, Rheinmetall, Almonty Industries - Which momentum share is running out of steam?
Will the Rheinmetall share end its consolidation and rise to a new all-time high? The chances are good. The armaments group is receiving one order after another - most recently from the German government and Lithuania. Analysts believe the share has around 30% potential. The Almonty Industries share has gained around 30% in recent months. The momentum for the tungsten producer is likely to continue. In China - the number one producer country - prices are rising to a 10-year high, and production is falling at the same time. This could hardly be a better time for Almonty to commission a new mine. The share price momentum at Nel ASA seems to be running out of steam. Or can the latest news provide support?
Read